Art

J-GLOBAL ID：201902260892239121   Reference number：19A0982330

Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study

Glaucomaまたは眼高血圧症の日本人患者におけるリパズジルの安全性および有効性: 市販後調査研究の3か月中間分析【JST・京大機械翻訳】

Author (7)： Tanihara Hidenobu (Kumamoto University Hospital, Kumamoto, Japan) ,  Kakuda Takahiko (Post Marketing Surveillance Department, Kowa Company, Ltd., Tokyo, Japan) ,  Sano Tetsuro (Post Marketing Surveillance Department, Kowa Company, Ltd., Tokyo, Japan) ,  Kanno Takashi (Post Marketing Surveillance Department, Kowa Company, Ltd., Tokyo, Japan) ,  Imada Ryosuke (Post Marketing Surveillance Department, Kowa Company, Ltd., Tokyo, Japan) ,  Shingaki Wataru (Post Marketing Surveillance Department, Kowa Company, Ltd., Tokyo, Japan) ,  Gunji Ryoji (Post Marketing Surveillance Department, Kowa Company, Ltd., Tokyo, Japan)
Material： Advances in Therapy
Volume： 36  Issue： 2  Page： 333-343  Publication year： 2019 
JST Material Number： W4004A  ISSN： 1865-8652  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Abstract/Point： To evaluate the safety and int...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0982330&from=J-GLOBAL&jstjournalNo=W4004A") }}

Thesaurus term： *post marketing surveillance ,  *Safety ,  *effectiveness ,  Intraocular Pressure ,  ophthalmic solution ,  Tokyo Metropolis ,  *human ,  Glaucoma ,  internet ,  *Hypertension ,  Uveitis ,  effect ,  drug therapy ,  Glaucoma, Neovascular ,  Normal pressure glaucoma ,  *Japanese ,  ocular hypertension

Author keywords (9)： Efficacy ,  Glaucoma ,  Intraocular pressure ,  Observational study ,  Ophthalmology ,  Post-marketing surveillance ,  Ripasudil ,  ROCK inhibitor ,  Safety

JST classification (2)： Clinical application of drugs acting on sensory organs  (GW04070V) ,  Drug therapy(=pharmacotherapy)for eye diseases  (GP05020E)

Terms in the title (10)： 眼 ,  高血圧症 ,  日本人 ,  患者 ,  安全性 ,  有効性 ,  市販後調査 ,  研究 ,  月 ,  分析